The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences.
暂无分享,去创建一个
J. Pascussi | P. Maurel | Cédric Duret | S. Gerbal-Chaloin | Martine Daujat-Chavanieu | Patrick Maurel | Jean-Marc Pascussi | Sabine Gerbal-Chaloin | Cédric Duret | Martine Daujat-Chavanieu | Marie-José Vilarem | M. Vilarem
[1] L. Moore,et al. Functional and structural comparison of PXR and CAR. , 2003, Biochimica et biophysica acta.
[2] S. Surapureddi,et al. Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Fukamizu,et al. Hepatocyte Nuclear Factor-4 Is a Novel Downstream Target of Insulin via FKHR as a Signal-regulated Transcriptional Inhibitor* , 2003, The Journal of Biological Chemistry.
[4] B. Goodwin,et al. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. , 1999, Molecular pharmacology.
[5] E. Ben-Chetrit,et al. Colchicine: 1998 update. , 1998, Seminars in arthritis and rheumatism.
[6] B. Goodwin,et al. Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. , 2002, Molecular pharmacology.
[7] Sean Ekins,et al. A Ligand-Based Approach to Understanding Selectivity of Nuclear Hormone Receptors PXR, CAR, FXR, LXRα, and LXRβ , 2002, Pharmaceutical Research.
[8] M. Stoffel,et al. Insulin regulates the activity of forkhead transcription factor Hnf-3β/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Kliewer. Pregnane X receptor: predicting and preventing drug interactions. , 2005, Thrombosis research.
[10] D. Accili,et al. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.
[11] P. Watkins,et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. , 2006, The Journal of clinical investigation.
[12] J. Kraniak,et al. Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver. , 1998, Molecular Pharmacology.
[13] P. Watkins,et al. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. , 1997, Molecular pharmacology.
[14] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[15] Matthew D Krasowski,et al. Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts. , 2005, Molecular endocrinology.
[16] Bruce M. Spiegelman,et al. Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.
[17] D. Greenblatt,et al. Effects of the Antifungal Agents on Oxidative Drug Metabolism , 2000, Clinical pharmacokinetics.
[18] C. Carlberg,et al. Identification of pregnane X receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis. , 2005, Journal of molecular biology.
[19] J. Pascussi,et al. Expression of CYP3A4, CYP2B6, andCYP2C9 Is Regulated by the Vitamin D Receptor Pathway in Primary Human Hepatocytes* , 2002, The Journal of Biological Chemistry.
[20] E. Sotaniemi,et al. Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency. , 1989, Diabetes research.
[21] S. Matern,et al. Stimulation of bile acid 6α-hydroxylation by rifampin , 1996 .
[22] L. Poellinger,et al. Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide. , 2006, Cellular signalling.
[23] T. Sueyoshi,et al. Drug-activated nuclear receptors CAR and PXR , 2003, Annals of medicine.
[24] T. Sueyoshi,et al. The Nuclear Orphan Receptor CAR-Retinoid X Receptor Heterodimer Activates the Phenobarbital-Responsive Enhancer Module of the CYP2B Gene , 1998, Molecular and Cellular Biology.
[25] C. Handschin,et al. Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans. , 2001, Molecular endocrinology.
[26] M. Negishi,et al. CAR and PXR: The xenobiotic-sensing receptors , 2007, Steroids.
[27] P. Meier,et al. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. , 1999, Gastroenterology.
[28] O. Hankinson. Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. , 2005, Archives of biochemistry and biophysics.
[29] Wissem Mnif,et al. Estrogens and antiestrogens activate hPXR. , 2007, Toxicology letters.
[30] G. Williams,et al. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. , 2002, The Journal of endocrinology.
[31] D. Moore,et al. Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. , 2005, Endocrinology.
[32] Y. Liu,et al. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[33] T. Efferth,et al. Role of glucose-6-phosphate dehydrogenase for oxidative stress and apoptosis , 2006, Cell Death and Differentiation.
[34] J. Sumpter,et al. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. , 2000, The Journal of biological chemistry.
[35] C. Koike,et al. Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes , 2004, Molecular and Cellular Biology.
[36] A. Kong,et al. Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.
[37] D. Reinberg,et al. Transcription. Switching partners in a regulatory tango. , 2001, Science.
[38] Jerry Donovan,et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. , 2003, Nature.
[39] Alvaro Puga,et al. Ah receptor signals cross-talk with multiple developmental pathways. , 2005, Biochemical pharmacology.
[40] P. Maurel,et al. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. , 1990, Gastroenterology.
[41] Vincent Laudet,et al. Principles for modulation of the nuclear receptor superfamily , 2004, Nature Reviews Drug Discovery.
[42] J. Pascussi,et al. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. , 2003, Molecular pharmacology.
[43] Paul T Tarr,et al. Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.
[44] Christoph Handschin,et al. Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.
[45] David Carling,et al. The AMP-activated protein kinase cascade--a unifying system for energy control. , 2004, Trends in biochemical sciences.
[46] R. Pollenz,et al. Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. , 1999, Molecular pharmacology.
[47] J. Macías,et al. Relationship Between Low Bone Mineral Density and Highly Active Antiretroviral Therapy Including Protease Inhibitors in HIV-Infected Patients , 2003, HIV clinical trials.
[48] Guillaume Adelmant,et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.
[49] J. Pascussi,et al. Ketoconazole and Miconazole Are Antagonists of the Human Glucocorticoid Receptor: Consequences on the Expression and Function of the Constitutive Androstane Receptor and the Pregnane X Receptor , 2006, Molecular Pharmacology.
[50] J. Chiang,et al. Bile acid regulation of gene expression: roles of nuclear hormone receptors. , 2002, Endocrine reviews.
[51] C. Tohyama,et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor , 2003, Nature.
[52] Y. Gu,et al. Cross-talk between the Aryl Hydrocarbon Receptor and Hypoxia Inducible Factor Signaling Pathways , 1999, The Journal of Biological Chemistry.
[53] M. Kamiński,et al. Influence of cholesterol and protein diet on liver cytochrome P-450-dependent monooxygenase system in rats. , 1996, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[54] J. Thomsen,et al. The Orphan Nuclear Receptor SHP Inhibits Agonist-dependent Transcriptional Activity of Estrogen Receptors ERα and ERβ* , 1999, The Journal of Biological Chemistry.
[55] H. Adami,et al. RAPID HEALING OF DUODENAL ULCERS WITH OMEPRAZOLE: DOUBLE-BLIND DOSE-COMPARATIVE TRIAL , 1983, The Lancet.
[56] K. Wikvall,et al. 6α-Hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes , 1999 .
[57] C. Handschin,et al. Induction of drug metabolism: the role of nuclear receptors. , 2008, Pharmacological reviews.
[58] C. Glass,et al. Nuclear Integration of Glucocorticoid Receptor and Nuclear Factor-κB Signaling by CREB-binding Protein and Steroid Receptor Coactivator-1* , 1998, The Journal of Biological Chemistry.
[59] K. Wikvall,et al. Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5β-cholestane-3α,7α,12α-triol in human liver microsomes , 1999 .
[60] D. Hardie,et al. AMP-activated Protein Kinase Mediates Phenobarbital Induction of CYP2B Gene Expression in Hepatocytes and a Newly Derived Human Hepatoma Cell Line* , 2005, Journal of Biological Chemistry.
[61] W. L. Nelson,et al. Intestinal and Hepatic CYP3A4 Catalyze Hydroxylation of 1α,25-Dihydroxyvitamin D3: Implications for Drug-Induced Osteomalacia , 2006, Molecular Pharmacology.
[62] C. Mattingly,et al. Estrogen Receptor Reduces CYP1A1 Induction in Cultured Human Endometrial Cells* , 1999, The Journal of Biological Chemistry.
[63] U. Meyer,et al. In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase , 2007, Proceedings of the National Academy of Sciences.
[64] D. Kelly,et al. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. , 2006, The Journal of clinical investigation.
[65] A. Walsh,et al. Dietary Cholesterol Fails to Stimulate the Human Cholesterol 7α-Hydroxylase Gene (CYP7A1) in Transgenic Mice* 210 , 2002, The Journal of Biological Chemistry.
[66] R Ohlsson,et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[67] R. Evans,et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[68] J. Lehmann,et al. An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.
[69] K. Bock. Aryl hydrocarbon or dioxin receptor: biologic and toxic responses. , 1994, Reviews of physiology, biochemistry and pharmacology.
[70] J. Lahtela,et al. Enzyme Inducers Improve Insulin Sensitivity in Non-insulin-dependent Diabetic Subjects , 1985, Diabetes.
[71] T. Kocarek,et al. Regulation of sulfotransferases by xenobiotic receptors. , 2005, Current drug metabolism.
[72] J. Stengård,et al. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus. , 1989, Diabetes research.
[73] J. Chiang. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. , 2004, Journal of hepatology.
[74] E. Schuetz,et al. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. , 2001, Molecular pharmacology.
[75] T. Willson,et al. The Nuclear Receptor CAR Is a Regulator of Thyroid Hormone Metabolism during Caloric Restriction* , 2004, Journal of Biological Chemistry.
[76] J. S. Sidhu,et al. Insulin‐mediated modulation of cytochrome P450 gene induction profiles in primary rat hepatocyte cultures , 1999, Journal of biochemical and molecular toxicology.
[77] C. Klaassen,et al. Effects of Microsomal Enzyme Inducers on Thyroid Follicular Cell Proliferation and Thyroid Hormone Metabolism , 2001, Toxicologic pathology.
[78] J. Pascussi,et al. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. , 2000, Molecular pharmacology.
[79] J. Goldstein,et al. Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. , 2002, Molecular pharmacology.
[80] K. Wikvall,et al. 6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. , 1999, Biochimica et biophysica acta.
[81] T. Sueyoshi,et al. Nuclear Pregnane X Receptor Cross-talk with FoxA2 to Mediate Drug-induced Regulation of Lipid Metabolism in Fasting Mouse Liver* , 2007, Journal of Biological Chemistry.
[82] Hongbing Wang,et al. A Novel Distal Enhancer Module Regulated by Pregnane X Receptor/Constitutive Androstane Receptor Is Essential for the Maximal Induction of CYP2B6 Gene Expression* , 2003, The Journal of Biological Chemistry.
[83] D. DeFranco,et al. Inhibition of Glucocorticoid Receptor Nucleocytoplasmic Shuttling by Okadaic Acid Requires Intact Cytoskeleton* , 1999, The Journal of Biological Chemistry.
[84] C. Handschin,et al. Cholesterol and Bile Acids Regulate Xenosensor Signaling in Drug-mediated Induction of Cytochromes P450* , 2002, The Journal of Biological Chemistry.
[85] E. Morgan,et al. Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: independence from nitric oxide production by inducible nitric oxide synthase. , 2002, Biochemical pharmacology.
[86] G. Perdew,et al. Role of the aryl hydrocarbon receptor in drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.
[87] Allan B. Okey,et al. Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.
[88] Paavo Honkakoski,et al. The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene* , 1999, The Journal of Biological Chemistry.
[89] J. Pascussi,et al. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. , 2000, Molecular pharmacology.
[90] J. Brockmöller,et al. Increase of cytochrome P450IA2 activity by omeprazole: Evidence by the 13C‐[N‐3‐methyl]‐caffeine breath test in poor and extensive metabolizers of S‐mephenytoin , 1992, Clinical pharmacology and therapeutics.
[91] John T. Moore,et al. CAR: detailing new models. , 2004, Trends in pharmacological sciences.
[92] Jun Xia,et al. Structural Determinants of Constitutive Androstane Receptor Required for Its Glucocorticoid Receptor Interacting Protein-1-mediated Nuclear Accumulation* , 2005, Journal of Biological Chemistry.
[93] R. Evans,et al. Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice* , 2004, Journal of Biological Chemistry.
[94] S. Bhatia,et al. Hypoxic inhibition of 3-methylcholanthrene-induced CYP1A1 expression is independent of HIF-1alpha. , 2005, Toxicology letters.
[95] M. Ingelman-Sundberg,et al. Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation. , 2004, Molecular pharmacology.
[96] D. Reinberg,et al. Switching Partners in a Regulatory Tango , 2001, Science.
[97] A. Fukamizu,et al. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. , 2003, Diabetes.
[98] K. Guyton,et al. Cancer chemoprevention using natural vitamin D and synthetic analogs. , 2003, Annual review of pharmacology and toxicology.
[99] U. Meyer,et al. Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. , 2004, Pharmacogenetics.
[100] J. Peters,et al. Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[101] J. Pascussi,et al. Transcriptional Regulation of CYP2C9 Gene , 2002, The Journal of Biological Chemistry.
[102] M. Fromm,et al. Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver , 2003, Journal of Pharmacology and Experimental Therapeutics.
[103] G. Caramori,et al. Cross‐talk between pro‐inflammatory transcription factors and glucocorticoids , 2001, Immunology and cell biology.
[104] J. Pascussi,et al. Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. , 2003, Molecular endocrinology.
[105] V. Giguère,et al. Orphan nuclear receptors: from gene to function. , 1999 .
[106] J. Chiang,et al. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene. , 2003, Biochemical and biophysical research communications.
[107] T. Willson,et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[108] S. Kato. The function of vitamin D receptor in vitamin D action. , 2000, Journal of biochemistry.
[109] M. Gassmann,et al. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor , 1996, Molecular and cellular biology.
[110] P. Harper,et al. Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. , 2006, Biochemical pharmacology.
[111] B. O’Malley,et al. The Expanding Cosmos of Nuclear Receptor Coactivators , 2006, Cell.
[112] R. Evans,et al. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[113] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[114] P. Traber,et al. Induction of cytochrome P450IA genes (CYP1A) by omeprazole in the human alimentary tract. , 1992, Gastroenterology.
[115] Y. Fujii‐Kuriyama,et al. Regulation of Dioxin Receptor Function by Omeprazole* , 1997, The Journal of Biological Chemistry.
[116] B. Spiegelman,et al. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.
[117] C. Handschin,et al. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. , 2005, Archives of biochemistry and biophysics.
[118] A. Fukamizu,et al. Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1* , 2004, Journal of Biological Chemistry.
[119] H. Hellmold,et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. , 2005, Toxicology and applied pharmacology.
[120] J. Lehmann,et al. Orphan nuclear receptors: shifting endocrinology into reverse. , 1999, Science.
[121] C. Glass. Going nuclear in metabolic and cardiovascular disease. , 2006, The Journal of clinical investigation.
[122] Inder M Verma,et al. NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.
[123] X. Leverve,et al. Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital. , 1991, The Biochemical journal.
[124] J. Kemper,et al. Ligand-activated Pregnane X Receptor Interferes with HNF-4 Signaling by Targeting a Common Coactivator PGC-1α , 2004, Journal of Biological Chemistry.
[125] J. Pascussi,et al. Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences , 2004, Xenobiotica; the fate of foreign compounds in biological systems.
[126] E. Morgan. Regulation of cytochromes P450 during inflammation and infection. , 1997, Drug metabolism reviews.
[127] J. Pascussi,et al. Constitutive androstane receptor-vitamin D receptor crosstalk: consequence on CYP24 gene expression. , 2007, Biochemical and biophysical research communications.
[128] J. Pascussi,et al. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. , 2001, European journal of biochemistry.
[129] J. Lehmann,et al. Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.
[130] J. Gustafsson. What pharmacologists can learn from recent advances in estrogen signalling. , 2003, Trends in pharmacological sciences.
[131] M. Stoffel,et al. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes , 2004, Nature.
[132] R. Knutsen,et al. Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice , 2003, Nature Medicine.
[133] K. Wikvall,et al. Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in human liver microsomes. , 1999, Biochimica et biophysica acta.
[134] B. Blumberg,et al. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. , 2006, The Journal of clinical investigation.
[135] J. Pascussi,et al. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. , 2000, Biochemical and biophysical research communications.
[136] G. Perdew,et al. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. , 1999, The Journal of biological chemistry.
[137] G. Semenza,et al. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.
[138] A. Fukamizu,et al. Inhibitory Effect of the Small Heterodimer Partner on Hepatocyte Nuclear Factor-4 Mediates Bile Acid-induced Repression of the Human Angiotensinogen Gene* , 2004, Journal of Biological Chemistry.
[139] B. Viollet,et al. Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver , 2006, Molecular Pharmacology.
[140] S. Penzak,et al. Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment. , 2000, Scandinavian journal of infectious diseases.
[141] M. Castro‐Gago,et al. Long‐Term Treatment of Children with Epilepsy with Valproate or Carbamazepine May Cause Subclinical Hypothyroidism , 1999, Epilepsia.
[142] M. Gallo,et al. Mechanism of Suppression of Cytochrome P-450 1A1 Expression by Tumor Necrosis Factor-α and Lipopolysaccharide* , 2001, The Journal of Biological Chemistry.
[143] S. Kliewer,et al. Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity* , 2003, Journal of Biological Chemistry.
[144] D. Waxman,et al. Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR) , 2006, Drug metabolism reviews.
[145] W. Sabbagh,et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. , 1998, Genes & development.
[146] T. A. Kerr,et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.
[147] M. E. Hahn,et al. Aryl hydrocarbon receptors: diversity and evolution. , 2002, Chemico-biological interactions.
[148] J. Auwerx,et al. The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity. , 2002, Molecular endocrinology.
[149] Timothy M Willson,et al. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. , 2002, Molecular endocrinology.
[150] L. Moore,et al. Identification of a Novel Human Constitutive Androstane Receptor (CAR) Agonist and Its Use in the Identification of CAR Target Genes* , 2003, The Journal of Biological Chemistry.
[151] Y Fujii-Kuriyama,et al. Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. , 2005, Biochemical and biophysical research communications.
[152] S. Eaton,et al. Mammalian mitochondrial beta-oxidation. , 1996, The Biochemical journal.
[153] N. Mitro,et al. T0901317 is a potent PXR ligand: Implications for the biology ascribed to LXR , 2007, FEBS letters.
[154] F. Gonzalez,et al. Adipocyte-specific Gene Expression and Adipogenic Steatosis in the Mouse Liver Due to Peroxisome Proliferator-activated Receptor γ1 (PPARγ1) Overexpression* , 2003, The Journal of Biological Chemistry.
[155] J. Chiang,et al. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[156] E. Kanaya,et al. Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state. , 2003, The Journal of biological chemistry.
[157] F. Lasserre,et al. The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity. , 2003, Molecular endocrinology.
[158] B. Chatterjee,et al. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. , 2004, Molecular pharmacology.
[159] R. Evans,et al. A Novel Pregnane X Receptor-mediated and Sterol Regulatory Element-binding Protein-independent Lipogenic Pathway* , 2006, Journal of Biological Chemistry.
[160] B. M. Forman,et al. Peptide Mimetic HIV Protease Inhibitors Are Ligands for the Orphan Receptor SXR* , 2001, The Journal of Biological Chemistry.
[161] Marc Montminy,et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.
[162] M. Haussler,et al. Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.
[163] D. Moore,et al. Novel receptor interaction and repression domains in the orphan receptor SHP , 1997, Molecular and cellular biology.
[164] P. Balaguer,et al. Transcriptional Regulation of the Human NRIP1/RIP140 Gene by Estrogen Is Modulated by Dioxin Signalling , 2006, Molecular Pharmacology.
[165] Ji Miao,et al. Functional Inhibitory Cross-talk between Constitutive Androstane Receptor and Hepatic Nuclear Factor-4 in Hepatic Lipid/Glucose Metabolism Is Mediated by Competition for Binding to the DR1 Motif and to the Common Coactivators, GRIP-1 and PGC-1α* , 2006, Journal of Biological Chemistry.
[166] T. Sueyoshi,et al. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. , 2001, Annual review of pharmacology and toxicology.
[167] J. Reddy,et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. , 2003, The Journal of biological chemistry.
[168] Stephen Safe,et al. The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor α through Activation of Proteasomes , 2003, Molecular and Cellular Biology.
[169] S. Safe,et al. Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. , 2003, Chemical research in toxicology.
[170] Christoph Handschin,et al. Metabolic control through the PGC-1 family of transcription coactivators. , 2005, Cell metabolism.
[171] P. Meier,et al. Coordinate transcriptional regulation of transport and metabolism. , 2005, Methods in enzymology.
[172] Y. Fujii‐Kuriyama,et al. Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: their stabilization and redox signal‐induced interaction with CBP/p300 , 1999, The EMBO journal.
[173] J. Kemper,et al. Inhibitory Cross-talk between Estrogen Receptor (ER) and Constitutively Activated Androstane Receptor (CAR) , 2002, The Journal of Biological Chemistry.
[174] P. Puigserver,et al. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[175] J. Staudinger,et al. The Ratio of Constitutive Androstane Receptor to Pregnane X Receptor Determines the Activity of Guggulsterone against the Cyp2b10 Promoter , 2005, Journal of Pharmacology and Experimental Therapeutics.
[176] K. Matsui,et al. The Nuclear Receptor Constitutively Active/Androstane Receptor Regulates Type 1 Deiodinase and Thyroid Hormone Activity in the Regenerating Mouse Liver , 2007, Journal of Pharmacology and Experimental Therapeutics.
[177] C. Smith,et al. Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X Receptor , 2006, Journal of Pharmacology and Experimental Therapeutics.
[178] Sean Ekins,et al. A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta. , 2002, Pharmaceutical research.
[179] L. Laffel. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes , 1999, Diabetes/metabolism research and reviews.
[180] Pascal G. P. Martin,et al. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. , 2005, The Journal of clinical investigation.
[181] J. Pascussi,et al. Interleukin 1β inhibits CAR‐induced expression of hepatic genes involved in drug and bilirubin clearance , 2004, Hepatology.
[182] J. Sugatani,et al. The phenobarbital response enhancer module in the human bilirubin UDP‐glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR , 2001, Hepatology.
[183] S. Matern,et al. Stimulation of bile acid 6 alpha-hydroxylation by rifampin. , 1996, Journal of hepatology.
[184] S. Güngör,et al. Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children. , 2001, Acta neurologica Belgica.
[185] Tim Jordan,et al. Fox's in development and disease. , 2003, Trends in genetics : TIG.
[186] M. Norlin,et al. Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia. , 2007, Biochemical and biophysical research communications.
[187] D. Mangelsdorf,et al. Pregnane X Receptor Is a Target of Farnesoid X Receptor* , 2006, Journal of Biological Chemistry.
[188] F. Gonzalez,et al. The Coactivator PGC-1 Is Involved in the Regulation of the Liver Carnitine Palmitoyltransferase I Gene Expression by cAMP in Combination with HNF4α and cAMP-response Element-binding Protein (CREB)* , 2002, The Journal of Biological Chemistry.
[189] Oliver Burk,et al. Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin* , 2001, The Journal of Biological Chemistry.
[190] J. Pascussi,et al. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. , 2003, Biochimica et biophysica acta.
[191] Kazumi Ito,et al. Molecular mechanism investigation of phenobarbital-induced serum cholesterol elevation in rat livers by microarray analysis , 2004, Archives of Toxicology.